• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血红素加氧酶-1预测低级别胶质瘤的风险分层及免疫治疗疗效

Heme Oxygenase-1 Predicts Risk Stratification and Immunotherapy Efficacy in Lower Grade Gliomas.

作者信息

Ye Wenrui, Liu Zhixiong, Liu Fangkun, Luo Cong

机构信息

Department of Neurosurgery, Xiangya Hospital, Central South University (CSU), Changsha, China.

National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University (CSU), Changsha, China.

出版信息

Front Cell Dev Biol. 2021 Nov 9;9:760800. doi: 10.3389/fcell.2021.760800. eCollection 2021.

DOI:10.3389/fcell.2021.760800
PMID:34858984
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8631111/
Abstract

Gliomas are the most common tumors in human brains with unpleasing outcomes. Heme oxygenase-1 (, ) was a potential target for human cancers. However, their relationship remains incompletely discussed. We employed a total of 952 lower grade glioma (LGG) patients from TCGA and CGGA databases, and 29 samples in our hospital for subsequent analyses. Expression, mutational, survival, and immune profiles of were comprehensively evaluated. We constructed a risk signature using the LASSO Cox regression model, and further generated a nomogram model to predict survival of LGG patients. Single-cell transcriptomic sequencing data were also employed to investigated the role of in cancer cells. We found that was overexpressed and was related to poorer survival in gliomas. -related genes (HRGs) were involved in immune-related pathways. Patients in the high-risk group exhibited significantly poorer overall survival. The risk score was positively correlated with the abundance of resting memory CD4+ T cells, M1, M2 macrophages, and activated dendritic cells. Additionally, immunotherapy showed potent efficacy in low-risk group. And patients with lower expression were predicted to have better response to immunotherapies, suggesting that immunotherapies combined with inhibition may execute good responses. Moreover, significant correlations were found between expression and single-cell functional states including angiogenesis, hypoxia, and metastasis. Finally, we constructed a nomogram which could predict 1-, 3-, and 5-year survival in LGG patients. is involved in immune infiltration and predicts poor survival in patients with lower grade glioma. Importantly, were related to oncological functional states including angiogenesis, hypoxia, and metastasis. A nomogram integrated with the risk signature was obtained to robustly predict glioma patient outcomes, with the potential to guide clinical decision-making.

摘要

胶质瘤是人类大脑中最常见的肿瘤,预后不佳。血红素加氧酶-1(HO-1)是人类癌症的一个潜在靶点。然而,它们之间的关系仍未得到充分讨论。我们从TCGA和CGGA数据库中总共纳入了952例低级别胶质瘤(LGG)患者,并收集了我院的29份样本进行后续分析。全面评估了HO-1的表达、突变、生存和免疫特征。我们使用LASSO Cox回归模型构建了一个风险特征,并进一步生成了一个列线图模型来预测LGG患者的生存情况。还利用单细胞转录组测序数据研究了HO-1在癌细胞中的作用。我们发现HO-1在胶质瘤中过度表达,且与较差的生存相关。HO-1相关基因(HRGs)参与免疫相关途径。高风险组患者的总生存期明显较差。风险评分与静息记忆CD4+ T细胞、M1、M2巨噬细胞和活化树突状细胞的丰度呈正相关。此外,免疫疗法在低风险组显示出强大的疗效。HO-1表达较低的患者预计对免疫疗法有更好的反应,这表明免疫疗法联合HO-1抑制可能会产生良好的反应。此外,发现HO-1表达与包括血管生成、缺氧和转移在内的单细胞功能状态之间存在显著相关性。最后,我们构建了一个列线图,可以预测LGG患者1年、3年和5年的生存率。HO-1参与免疫浸润,并预测低级别胶质瘤患者的生存较差。重要的是,HO-1与包括血管生成、缺氧和转移在内的肿瘤功能状态相关。获得了一个与风险特征相结合的列线图,以可靠地预测胶质瘤患者的预后,有可能指导临床决策。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12d7/8631111/e1086daa6910/fcell-09-760800-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12d7/8631111/e10626047eed/fcell-09-760800-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12d7/8631111/6a465e4bd095/fcell-09-760800-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12d7/8631111/0ee389c77d2c/fcell-09-760800-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12d7/8631111/0966900ee048/fcell-09-760800-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12d7/8631111/5e75a828f8bd/fcell-09-760800-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12d7/8631111/e1086daa6910/fcell-09-760800-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12d7/8631111/e10626047eed/fcell-09-760800-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12d7/8631111/6a465e4bd095/fcell-09-760800-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12d7/8631111/0ee389c77d2c/fcell-09-760800-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12d7/8631111/0966900ee048/fcell-09-760800-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12d7/8631111/5e75a828f8bd/fcell-09-760800-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12d7/8631111/e1086daa6910/fcell-09-760800-g006.jpg

相似文献

1
Heme Oxygenase-1 Predicts Risk Stratification and Immunotherapy Efficacy in Lower Grade Gliomas.血红素加氧酶-1预测低级别胶质瘤的风险分层及免疫治疗疗效
Front Cell Dev Biol. 2021 Nov 9;9:760800. doi: 10.3389/fcell.2021.760800. eCollection 2021.
2
Immune Infiltration-Related Signature Predicts Risk Stratification and Immunotherapy Efficacy in Grade II and III Gliomas.免疫浸润相关特征预测II级和III级胶质瘤的风险分层及免疫治疗疗效
Front Cell Dev Biol. 2021 Nov 5;9:756005. doi: 10.3389/fcell.2021.756005. eCollection 2021.
3
Elevated TYROBP expression predicts poor prognosis and high tumor immune infiltration in patients with low-grade glioma.TYROBP 表达升高预示低级别胶质瘤患者预后不良和肿瘤免疫浸润程度高。
BMC Cancer. 2021 Jun 23;21(1):723. doi: 10.1186/s12885-021-08456-6.
4
An Immune-Related Signature for Predicting the Prognosis of Lower-Grade Gliomas.预测低级别胶质瘤预后的免疫相关标志物。
Front Immunol. 2020 Dec 8;11:603341. doi: 10.3389/fimmu.2020.603341. eCollection 2020.
5
Development and Verification of Glutamatergic Synapse-Associated Prognosis Signature for Lower-Grade Gliomas.低级别胶质瘤谷氨酸能突触相关预后标志物的开发与验证
Front Mol Neurosci. 2021 Oct 28;14:720899. doi: 10.3389/fnmol.2021.720899. eCollection 2021.
6
A Poliovirus Receptor (CD155)-Related Risk Signature Predicts the Prognosis of Bladder Cancer.一种脊髓灰质炎病毒受体(CD155)相关风险特征预测膀胱癌的预后。
Front Oncol. 2021 Jun 3;11:660273. doi: 10.3389/fonc.2021.660273. eCollection 2021.
7
Prognostic Model and Nomogram Construction Based on a Novel Ferroptosis-Related Gene Signature in Lower-Grade Glioma.基于低级别胶质瘤中一种新型铁死亡相关基因特征的预后模型和列线图构建
Front Genet. 2021 Nov 8;12:753680. doi: 10.3389/fgene.2021.753680. eCollection 2021.
8
Development of a nomogram for prognostic prediction of lower-grade glioma based on alternative splicing signatures.基于剪接变异特征的低级别胶质瘤预后预测列线图的构建。
Cancer Med. 2020 Dec;9(24):9266-9281. doi: 10.1002/cam4.3530. Epub 2020 Oct 13.
9
Development and Validation of a Tumor Mutation Burden-Related Immune Prognostic Model for Lower-Grade Glioma.低级别胶质瘤肿瘤突变负荷相关免疫预后模型的建立与验证
Front Oncol. 2020 Aug 20;10:1409. doi: 10.3389/fonc.2020.01409. eCollection 2020.
10
A Ferroptosis-Related Gene Prognostic Index to Predict Temozolomide Sensitivity and Immune Checkpoint Inhibitor Response for Glioma.一种用于预测胶质瘤替莫唑胺敏感性和免疫检查点抑制剂反应的铁死亡相关基因预后指数
Front Cell Dev Biol. 2022 Jan 31;9:812422. doi: 10.3389/fcell.2021.812422. eCollection 2021.

引用本文的文献

1
Ferroptosis-Related Transcriptional Level Changes and the Role of CIRBP in Glioblastoma Cells Ferroptosis.铁死亡相关转录水平变化及CIRBP在胶质母细胞瘤细胞铁死亡中的作用
Biomedicines. 2024 Dec 27;13(1):41. doi: 10.3390/biomedicines13010041.
2
Heme catabolism and heme oxygenase-1-expressing myeloid cells in pathophysiology.血红素代谢与血红素氧合酶-1 表达的髓系细胞在病理生理学中的作用。
Front Immunol. 2024 Oct 24;15:1433113. doi: 10.3389/fimmu.2024.1433113. eCollection 2024.
3
Unveiling the Molecular Mechanisms of Glioblastoma through an Integrated Network-Based Approach.

本文引用的文献

1
Immune Infiltrating Cells-Derived Risk Signature Based on Large-scale Analysis Defines Immune Landscape and Predicts Immunotherapy Responses in Glioma Tumor Microenvironment.基于大规模分析的免疫浸润细胞衍生风险特征可定义胶质细胞瘤肿瘤微环境中的免疫景观并预测免疫治疗反应。
Front Immunol. 2021 Aug 13;12:691811. doi: 10.3389/fimmu.2021.691811. eCollection 2021.
2
Elevated TYROBP expression predicts poor prognosis and high tumor immune infiltration in patients with low-grade glioma.TYROBP 表达升高预示低级别胶质瘤患者预后不良和肿瘤免疫浸润程度高。
BMC Cancer. 2021 Jun 23;21(1):723. doi: 10.1186/s12885-021-08456-6.
3
S100A gene family: immune-related prognostic biomarkers and therapeutic targets for low-grade glioma.
通过基于整合网络的方法揭示胶质母细胞瘤的分子机制。
Biomedicines. 2024 Oct 1;12(10):2237. doi: 10.3390/biomedicines12102237.
4
The promise of targeting heme and mitochondrial respiration in normalizing tumor microenvironment and potentiating immunotherapy.靶向血红素和线粒体呼吸在使肿瘤微环境正常化及增强免疫治疗方面的前景。
Front Oncol. 2023 Jan 4;12:1072739. doi: 10.3389/fonc.2022.1072739. eCollection 2022.
5
To Explore the Inhibitory Mechanism of Quercetin in Thyroid Papillary Carcinoma through Network Pharmacology and Experiments.基于网络药理学和实验探究槲皮素对甲状腺乳头状癌的抑制作用机制。
Dis Markers. 2022 Dec 3;2022:9541080. doi: 10.1155/2022/9541080. eCollection 2022.
S100A 基因家族:低级别胶质瘤的免疫相关预后生物标志物和治疗靶点。
Aging (Albany NY). 2021 Jun 8;13(11):15459-15478. doi: 10.18632/aging.203103.
4
The Predictive Value of Monocytes in Immune Microenvironment and Prognosis of Glioma Patients Based on Machine Learning.基于机器学习的单核细胞在免疫微环境及脑胶质瘤患者预后中的预测价值。
Front Immunol. 2021 Apr 16;12:656541. doi: 10.3389/fimmu.2021.656541. eCollection 2021.
5
Bioinformatics and survival analysis of glia maturation factor-γ in pan-cancers.胶质细胞成熟因子-γ 在多种癌症中的生物信息学和生存分析。
BMC Cancer. 2021 Apr 17;21(1):423. doi: 10.1186/s12885-021-08163-2.
6
The migration behavior of human glioblastoma cells is influenced by the redox-sensitive human macrophage capping protein CAPG.人源 CAPG 蛋白对人源脑胶质瘤细胞迁移行为的影响与氧化还原敏感性有关。
Free Radic Biol Med. 2021 May 1;167:81-93. doi: 10.1016/j.freeradbiomed.2021.02.038. Epub 2021 Mar 10.
7
Six Immune Associated Genes Construct Prognostic Model Evaluate Low-Grade Glioma.六个免疫相关基因构建预后模型评估低级别胶质瘤
Front Immunol. 2020 Dec 21;11:606164. doi: 10.3389/fimmu.2020.606164. eCollection 2020.
8
GNG5 is an unfavourable independent prognostic indicator of gliomas.GNG5 是胶质瘤的一个不利的独立预后指标。
J Cell Mol Med. 2020 Nov;24(21):12873-12878. doi: 10.1111/jcmm.15923. Epub 2020 Sep 30.
9
Identification of Immune-Related Genes Contributing to the Development of Glioblastoma Using Weighted Gene Co-expression Network Analysis.基于加权基因共表达网络分析鉴定与胶质母细胞瘤发生发展相关的免疫相关基因。
Front Immunol. 2020 Jul 16;11:1281. doi: 10.3389/fimmu.2020.01281. eCollection 2020.
10
Integrated analysis identified CAPG as a prognosis factor correlated with immune infiltrates in lower-grade glioma.综合分析确定CAPG是与低级别胶质瘤免疫浸润相关的预后因素。
Clin Transl Med. 2020 Jun;10(2):e51. doi: 10.1002/ctm2.51. Epub 2020 Jun 14.